Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | P2 - Poster Session 2

Saturday 04/02/22
11:45 AM - 12:45 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM PDT Abstract 9-001 - Approach to patients with autoimmune encephalitis with no identifiable antibodies
Carolina Gil Tommee, MD
11:45 AM - 12:45 PM PDT Abstract 9-002 - Co-Occurrence of Sj/ITPR1 and NMDA Antibodies: A Case Report
Dan Chapman, DO
11:45 AM - 12:45 PM PDT Abstract 9-003 - Isolated headache as the sole manifestation of autoimmune GFAP astrocytopathy
Eslam H. Shosha, MD
11:45 AM - 12:45 PM PDT Abstract 9-004 - A Curious Case of LGI1 Autoimmune Encephalitis Presenting as Chronic Hyponatremia and Subacute Dementia Without Faciobrachial Dystonic Seizures
Joshua Luster, MD
11:45 AM - 12:45 PM PDT Abstract 9-005 - New Onset Seizures and Rapidly Progressive Cognitive Impairment in a Patient With Prion Negative 14-3-3 Tauopathy and GABA- B Receptor Antibody Encephalitis: Case Report and Literature Review
Schweta P. Rane, MBBS
11:45 AM - 12:45 PM PDT Abstract 9-006 - Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting as Dementia with Lewy Bodies
Caroline Olvera, MD
11:45 AM - 12:45 PM PDT Abstract 9-007 - A Case of Opsoclonus-Myoclonus Ataxia with Neuronal Intermediate Filament IgG Detected in CSF
Melody Merati, DO
11:45 AM - 12:45 PM PDT Abstract 15-001 - Effect of Strong P-gp and BCRP Inhibition, Using Cyclosporine and Quinidine as Probes, on the Pharmacokinetics of Oral Rimegepant 75 mg in Healthy Subjects
Richard Bertz
11:45 AM - 12:45 PM PDT Abstract 15-002 - Acute Treatment with Oral Rimegepant 75 mg Reduces Migraine-Related Disability in Adults With and Without a History of Triptan Treatment Failure: Results from a One-Year, Open-Label Safety Study
Christopher Jensen, PharmD
11:45 AM - 12:45 PM PDT Abstract 15-003 - Within-Person Consistency of Acute Treatment Success With Ubrogepant: Results From a Long-term Safety Study
Aubrey Adams, PhD
11:45 AM - 12:45 PM PDT Abstract 15-004 - Evaluation of the Pharmacokinetic Interaction and Safety of Coadministered Atogepant and Topiramate
11:45 AM - 12:45 PM PDT Abstract 15-005 - Post-hoc Analysis of Safety in Phase 3 Atogepant ADVANCE Trial Participants with or without Cardiovascular Disease Risk Factors
Brett Dabruzzo, PharmD
11:45 AM - 12:45 PM PDT Abstract 15-006 - An Open-label, Intermediate-sized, Expanded Access Protocol of Rimegepant in the Acute Treatment of Migraine
Christopher Jensen, PharmD
11:45 AM - 12:45 PM PDT Abstract 3-001 - Proteostasis Network Changes in Dermal Fibroblasts in Aging and Neurodegeneration
Ashlyn G. Johnson
11:45 AM - 12:45 PM PDT Abstract 3-002 - Chromatin accessibility differences between African and European Alzheimer Disease brains.
11:45 AM - 12:45 PM PDT Abstract 3-003 - Improving Precision For Early Detection of Stroke Risk: Biological Aging Physiology and DNA methylation Cross-Talk
Reem Waziry, PhD, MBBCh, MPH
11:45 AM - 12:45 PM PDT Abstract 3-004 - AMPKa2 and Neuronal Structure: Implications for Metformin
Jonas Kruse
11:45 AM - 12:45 PM PDT Abstract 3-005 - The Effects of Prolonged Water-Only Fasting on Senescence Associated Secretory Phenotype
Eugene L. Scharf, MD
11:45 AM - 12:45 PM PDT Abstract 12-001 - Elevated Serum Glial Fibrillary Acidic Protein is a Biomarker of Disease Progression in Progressive Multiple Sclerosis Patients
Christian Barro, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 12-002 - Association Between Serum Glial Fibrillary Acidic Protein and Retinal Structural Changes in Patients with AQP4-antibody Positive Neuromyelitis Optica Spectrum Disorder
Ting-Yi Lin, MD
11:45 AM - 12:45 PM PDT Abstract 12-003 - Superiority of Serum NFL in Predicting Multiple Sclerosis Severity
Bibiana Bielekova, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 12-004 - miRNA as biomarkers of NEDA-3 in multiple sclerosis patients treated with fingolimod, glatiramer acetate and dimethyl-fumarate: Preliminary results
Hrishikesh A. Lokhande
11:45 AM - 12:45 PM PDT Abstract 12-005 - Functional analysis of validated miRNAs associated with MS disability
Hrishikesh A. Lokhande
11:45 AM - 12:45 PM PDT Abstract 12-006 - The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system
11:45 AM - 12:45 PM PDT Abstract 12-007 - Exploratory Analysis of Serum GDF-15 Levels in Patients Receiving Subcutaneous Interferon ß-1a in the REFLEX Trial
Elisabetta Verdun Di Cantogno, MD
11:45 AM - 12:45 PM PDT Abstract 12-008 - Cortical remyelination failure predicts cortical atrophy and clinical progression in early multiple sclerosis
Andrea Lazzarotto
11:45 AM - 12:45 PM PDT Abstract 12-009 - Association of Neuroaxonal and Glial Biomarkers with Clinical Phenotype in Underrepresented Minority Multiple Sclerosis Populations
Neda Sattarnezhad Oskouei, MD
11:45 AM - 12:45 PM PDT Abstract 12-010 - COVID19 infections in patients with Multiple Sclerosis (MS) on Various treatments at Kaiser Permanent Mid-Atlantic States (KPMAS)
Kyle Tse, MD
11:45 AM - 12:45 PM PDT Abstract 12-011 - The impact of COVID-19 on the disease activity of multiple sclerosis: A Retrospective cohort study
11:45 AM - 12:45 PM PDT Abstract 6-001 - NMDAR-Ab Encephalitis Presenting as a Rett Syndrome Mimic in a 2 year old
Young-Min Kim, MD
11:45 AM - 12:45 PM PDT Abstract 6-002 - Neurodegenerative Encephalomyelopathy Associated with ACOX-1 Gain-of-Function Mutation Partially Responsive to Immunotherapy
Mellad Khoshnood, MD
11:45 AM - 12:45 PM PDT Abstract 6-003 - Expanding the Phenotypic Spectrum of ECEL1-Associated Distal Arthrogryposis
11:45 AM - 12:45 PM PDT Abstract 6-004 - The Mitochondrial Neurodegenerative Diseases MELAS and LHON-Plus: How Translational Research Converts Challenges into Therapeutic Opportunities and Clinical Trial Design
Andrea L. Gropman, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 6-005 - FARSA Mutations Causing Cerebral Microcysts, Cystic Interstitial Lung Disease, Growth Restriction, and Developmental Delay
Charles J. Kidd, MD
11:45 AM - 12:45 PM PDT Abstract 7-001 - The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review
Manizhe Eslami-Amirabadi, MD
11:45 AM - 12:45 PM PDT Abstract 7-002 - Factors Influencing Compliance in Independent In-Home Exercise Trial for Older Adults
Margaret Kelly Specht
11:45 AM - 12:45 PM PDT Abstract 7-003 - Delayed Leukoencephalopathy after an Opioid-related Acute Amnestic Syndrome
Brady T. Mannett, DO
11:45 AM - 12:45 PM PDT Abstract 7-004 - Keep it in Sight: A Case of the Heidenhain Variant in Creutzfeldt-Jakob Disease
Claudia Vallin, DO
11:45 AM - 12:45 PM PDT Abstract 7-005 - A case of apperceptive visual agnosia mistaken for Broca aphasia
Manizhe Eslami-Amirabadi, MD
11:45 AM - 12:45 PM PDT Abstract 1-001 - Validation of a Clinical Scale for Defining RBD Severity in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium
Andrea O. Busicescu
11:45 AM - 12:45 PM PDT Abstract 1-002 - Symptom Severity and Treatment Satisfaction in Patients With Idiopathic Hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
Logan D. Schneider, MD
11:45 AM - 12:45 PM PDT Abstract 1-003 - Where do patients get diagnosed with idiopathic Rapid Eye Movement Behavior Disorder?
Isabelle Havis
11:45 AM - 12:45 PM PDT Abstract 1-004 - Development and Description of the International RBD Study Group RBD Symptom Severity Scale
Ronald Postuma, MD
11:45 AM - 12:45 PM PDT Abstract 1-005 - Factors Associated with Sleep Disturbance after Hemorrhagic Stroke
Ariane Lewis, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 10-001 - Position and Patient Safety Measures in the Epilepsy Monitoring Unit
Pamela O'Dea, MD
11:45 AM - 12:45 PM PDT Abstract 10-002 - NeuroMeasures™: Implementation of a Web-Based Real-Time Quality Metric Tool to Improve Provider Practices in an Epilepsy Clinic
Maryam J. Syed, MBBS
11:45 AM - 12:45 PM PDT Abstract 10-004 - Assessment of Adherence to Telehealth Versus In-person Epilepsy Clinic Visits in the Pre- and During COVID-19 Era
Saniya Pervin, MD
11:45 AM - 12:45 PM PDT Abstract 10-005 - Seizure Control During COVID-19: A Study Using the Responsive Neurostimulation System (RNS)
Ryan Ward
11:45 AM - 12:45 PM PDT Abstract 10-006 - COVID-19 Patient's Background Frequency on EEG Predictive of Hospital Discharge Disposition
Wonhee Lee, MD
11:45 AM - 12:45 PM PDT Abstract 10-007 - Ensuring the Continuity of Data Collection in a Focal Epilepsy Clinical Trial During the COVID-19 Pandemic
Lilly Frohlich, MPH
11:45 AM - 12:45 PM PDT Abstract 4-001 - A Novel Case of Longitudinally Extensive Transverse Myelitis following COVID-19 Vaccination in a Pediatric Patient
Amna Imran, MD
11:45 AM - 12:45 PM PDT Abstract 4-002 - Acute Transverse Myelitis: an upcoming complication of COVID-19 infection
Harshadayani Jagadish Kumar, MBBS
11:45 AM - 12:45 PM PDT Abstract 4-003 - Transverse Myelitis associated with COVID-19 in adults
Allyson Heng, MD
11:45 AM - 12:45 PM PDT Abstract 4-004 - Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Neuroinfectious Diseases
Abhilasha P. Boruah
11:45 AM - 12:45 PM PDT Abstract 4-005 - Inclusion Criteria for Sending Cerebrospinal Fluid pathogen Metagenomic Next-Generation Sequencing
Lei Liu, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 4-006 - Atypical Presentation of Neurosarcoidosis: A Case Report
Cleo Zarina A. Reyes, MD
11:45 AM - 12:45 PM PDT Abstract 4-007 - Delayed Toxic Encephalopathy Masquerading as Creutzfeldt-Jakob disease
Cory P. Hackmyer, DO
11:45 AM - 12:45 PM PDT Abstract 13-001 - Acute Embolic Stroke Presenting With Complete Hearing Loss
Ventaka Bendi, MBBS
11:45 AM - 12:45 PM PDT Abstract 13-002 - Reversible rapidly progressive dementia due to a high-grade, dural arteriovenous fistula: a case report
Juan J. Mendez Gallardo, MD
11:45 AM - 12:45 PM PDT Abstract 13-003 - Cerebral Venous Thrombosis: A Possible Complication of Clomiphene Therapy for in vitro Fertilization
Moises-Zacariah Garcia
11:45 AM - 12:45 PM PDT Abstract 13-004 - Iron Deficiency Anemia with Reactive Thrombocytosis Associated with Internal Carotid Artery Thrombus and Ischemic Infarction
Ashley Nelson, DO
11:45 AM - 12:45 PM PDT Abstract 13-005 - Can she ever fly again? A curious case of a PICA infarct in a healthy woman at high altitude and a review of known cerebrovascular changes at high elevations
William Hoffman, MD
11:45 AM - 12:45 PM PDT Abstract 13-006 - Case Report of Takayasu Arteritis Presenting as Stroke
Sean W. Scarpiello, MD
11:45 AM - 12:45 PM PDT Abstract 13-007 - Isolated Abducens Nerve Palsy as a Presentation of Extracranial Internal Carotid Artery Dissection: A Case Report
Keyvan Heshmati, MD
11:45 AM - 12:45 PM PDT Abstract 13-009 - Horizontal Gaze Palsy in Two Patients with Subcortical Stroke. Case Report
Leigham Breckenridge
11:45 AM - 12:45 PM PDT Abstract 13-010 - Retinal Claudication: A Rare Case of Light-Induced Amaurosis Fugax Secondary to Occlusive Carotid Artery Disease.
Ahmer Asif, MD
11:45 AM - 12:45 PM PDT Abstract 5-001 - Real-World Outcomes Using a Novel Directional DBS System for Parkinson's disease
Guenther Deuschl, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 5-002 - Social Support and Clinical Outcomes in Patients with Parkinson Disease After Deep Brain Stimulation
Sydney M. Spagna, MD
11:45 AM - 12:45 PM PDT Abstract 5-003 - Real-World Deep Brain Stimulation Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control
Theresa A. Zesiewicz, MD
11:45 AM - 12:45 PM PDT Abstract 5-004 - Outcomes After IPG Replacement Surgery Near End of Life in Parkinson’s Disease
Charlotte Wahle
11:45 AM - 12:45 PM PDT Abstract 5-005 - Effectiveness of Clinical Decision Support for the California Parkinson’s Disease Registry
11:45 AM - 12:45 PM PDT Abstract 5-006 - Impact of caregiver characteristics on patient outcomes in Parkinson’s disease
Rudmila Rashid, MD
11:45 AM - 12:45 PM PDT Abstract 5-007 - Tandem gait step-width declines more rapidly in a stage-dependent manner with Parkinson’s disease progression
Jennie Burns, MD
11:45 AM - 12:45 PM PDT Abstract 2-001 - Assessment of Olfactory Function in Classical (Infratentorial) Superficial Siderosis
Natallia Kharytaniuk, MBBS
11:45 AM - 12:45 PM PDT Abstract 2-002 - Delayed Post-hypoxic Leukoencephalopathy Presenting as Acute Psychosis without Focal Neurologic Deficits
Jeff W. Jin
11:45 AM - 12:45 PM PDT Abstract 2-003 - Diffusion restriction in the splenium of the corpus callosum: Clinical presentation, neuro-imaging findings, and hospitalization outcomes
Brian Stamm, MD
11:45 AM - 12:45 PM PDT Abstract 2-004 - Hypoxic-ischemic Injury as a Rare Complication of Sudden Severe Anemia
Alexandre Mason Sharma, MD
11:45 AM - 12:45 PM PDT Abstract 2-005 - Ascorbic Acid Deficiency As Culprit Of Cortical Spontaneous Subarachnoid Hemorrhage. Case Report And Literature Review.
Veronica A. Moreno Gomez, MD
11:45 AM - 12:45 PM PDT Abstract 11-001 - Retrospective Review of Outcomes After Intervention for Enteral Nutrition in ALS Patients Enrolled in Midwest Multi-disciplinary ALS Clinics
Timothy R. Fullam, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 11-002 - Is There Any Association Between the Prevalence of ALS and Exposure to Hazardous Wastes? A Statewide Planning and Research Cooperative System (SPARCS) Study (2002-2014)
Mustafa Jaffry
11:45 AM - 12:45 PM PDT Abstract 11-003 - Use of Electrical Impedance Tomography to Assess Pulmonary Function in ALS Patients
Courtney E. McIlduff, MD
11:45 AM - 12:45 PM PDT Abstract 11-004 - Continued Intravenous Edaravone Treatment in Patients with Amyotrophic Lateral Sclerosis (ALS) Increases Overall Survival Compared With No Intravenous Edaravone Treatment: Results from a US Administrative Claims Database
Benjamin R. Brooks, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 11-005 - Treatment Outcomes Among Amyotrophic Lateral Sclerosis Patients Receiving Intravenous Edaravone (IV): 44 Months of Follow-up From US Specialty Infusion Centers
Malgorzata Ciepielewska
11:45 AM - 12:45 PM PDT Abstract 11-006 - Clinical and Electrophysiological Findings in C9orf72 ALS
Carolina Parra Cantu, MD
11:45 AM - 12:45 PM PDT Abstract 11-007 - Prognosis of Pathologically Confirmed Japanese Amyotrophic Lateral Sclerosis with Tracheostomy Invasive Ventilation, a Retrospective Institute-based Study
Kiyonobu Komai, MD
11:45 AM - 12:45 PM PDT Abstract 11-008 - Study Design for a Phase 3, Multicenter, Open-Label, Safety Extension Study of Oral Edaravone Administered Over 96 Weeks in Patients with ALS (MT-1186-A03)
Alejandro Salah, MD, PhD, MBA, MHA
Faculty Disclosures
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Alon Y. Avidan, MD, MPH, FAAN Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Phyllis C. Zee, MD, PhD Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for World Sleep Society. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Brain Foundation. An immediate family member of Dr. Zee has stock in Teva. An immediate family member of Dr. Zee has stock in Pfizer. The institution of Dr. Zee has received research support from National Institutes of Health. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Elijah Stommel, MD, FAAN Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Devon I. Rubin, MD, FAAN Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Emmanuel Mignot, MD, PhD Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa .
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Bibiana Bielekova, MD, FAAN Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Joseph P. Broderick, MD, FAAN The institution of Dr. Broderick has received research support from Novo Nordisk. Dr. Broderick has received publishing royalties from a publication relating to health care.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Mark S. Quigg, MD Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
Jeffery Vance, MD, PhD Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Bjorn E. Oskarsson, MD, FAAN Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
J. Americo M. Fernandes, Jr., MD, FAAN Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
John Q. Trojanowski, MD, PhD Dr. Trojanowski has nothing to disclose.
Maria Laura Stromillo, PhD Maria Laura Stromillo, PhD has nothing to disclose.
Nicola De Stefano, MD Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Susan Criswell, MD Dr. Criswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie.
Jennifer A. Frontera, MD Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Chong S. Lee, MD, FRCPC Dr. Lee has nothing to disclose.
Jill L. Ostrem, MD, FAAN Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
No disclosure on file
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Aleksandar Videnovic, MD, MSc, FAAN Dr. Videnovic has nothing to disclose.
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Edward J. Cupler, MD, FAAN Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Allan D. Wu, MD, FAAN Dr. Wu has a non-compensated relationship as a Neuroscience Steering Board with Epic that is relevant to AAN interests or activities. Dr. Wu has a non-compensated relationship as a Subject Matter Expert Panel with Michael J Fox Foundation that is relevant to AAN interests or activities. Dr. Wu has a non-compensated relationship as a Advisory Committee with Parkinson Foundation that is relevant to AAN interests or activities. Dr. Wu has a non-compensated relationship as a Advisory Board with Brain and Life that is relevant to AAN interests or activities. An immediate family member of Dr. Wu has a non-compensated relationship as a Board Member with Illinois State Neurologic Society that is relevant to AAN interests or activities.
Stephanie J. Nahas, MD, FAAN Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to AAN interests or activities.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Antonio Arauz, MD, PhD Dr. Arauz has nothing to disclose.
David Shprecher, DO, FAAN Dr. Shprecher has received personal compensation for serving as an employee of Banner Health. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanders+Parks. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medplace. The institution of Dr. Shprecher has received research support from MJFF. The institution of Dr. Shprecher has received research support from Cognition Therapeutics. The institution of Dr. Shprecher has received research support from Biogen. The institution of Dr. Shprecher has received research support from Neuraly. The institution of Dr. Shprecher has received research support from Jazz Pharmaceuticals. The institution of Dr. Shprecher has received research support from Sanofi Aventis. The institution of Dr. Shprecher has received research support from Annovis. The institution of Dr. Shprecher has received research support from Neurocrine. The institution of Dr. Shprecher has received research support from Teva. The institution of Dr. Shprecher has received research support from Nuvelution. The institution of Dr. Shprecher has received research support from EIP Pharma. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson's and MDS. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Parkinson's Movement Disorder Alliance.
Ejaz Shamim, MD, MS, MBA, FAAN The institution of Dr. Shamim has received research support from Michael J. Fox Foundation.
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Daniel B. Hier, MD, MBA, FAAN Dr. Hier has nothing to disclose.
Aatif M. Husain, MD Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Methodist Hospital. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedIQ. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceutical. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. The institution of Dr. Husain has received research support from PranaQ. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with American Clinical Neurophysiology Society. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Kelvin L. Chou, MD, FAAN Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. The institution of Dr. Chou has received research support from NIH. The institution of Dr. Chou has received research support from Parkinson Study Group. The institution of Dr. Chou has received research support from Michael J Fox Foundation. The institution of Dr. Chou has received research support from Cerevance. Dr. Chou has received publishing royalties from a publication relating to health care. Dr. Chou has received publishing royalties from a publication relating to health care.
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Farzaneh A. Sorond, MD, PhD Dr. Sorond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Sorond has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. The institution of Dr. Sorond has received research support from NIH.
Paolo Gallo, MD Dr. Gallo has nothing to disclose.
Damiano Paolicelli Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Jean-Francois Gagnon The institution of Jean-Francois Gagnon has received research support from Canadian Institute of Health Research. The institution of Jean-Francois Gagnon has received research support from Canada Research Chair. The institution of Jean-Francois Gagnon has received research support from National Institutes of Health.
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has received publishing royalties from a publication relating to health care.
Teshamae Monteith, MD, FAAN Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
John Elliott No disclosure on file
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Mariann Polgar-Turcsanyi No disclosure on file
Nathan P. Staff, MD, PhD, FAAN Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Joyce K. Lee-Iannotti, MD, FAAN Dr. Lee-Iannotti has nothing to disclose.
Gustavo A. Suarez-Zambrano, MD Dr. Suarez-Zambrano has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America.
Kiran Thakur, MD, FAAN Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.
James X. Tao, MD, PhD Dr. Tao has nothing to disclose.
Bruno Stankoff, MD, PhD The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Carlos H. Schenck, MD Dr. Schenck has received personal compensation for serving as an employee of Physicians' Educational Resource, LLC.. Dr. Schenck has received personal compensation for serving as an employee of Eisai Global Medical Affairs.
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Michael Carrithers, MD, PhD The institution of Dr. Carrithers has received research support from Biogen.
Andrea L. Gropman, MD, FAAN Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor Mirica. Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Immedica. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health.
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Michael Khalil Michael Khalil has nothing to disclose.
Vikas Kotagal, MD, FAAN Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Rohit A. Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Sandra Weintraub, PhD, FAAN Dr. Weintraub has nothing to disclose.
Claudio Gasperini, MD Dr. Gasperini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche, Merck, Genzyme, Novartis,Bayer, Teva, Almirall.
Alexander U. Brandt, MD No disclosure on file
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Simona Ferioli, MD Dr. Ferioli has nothing to disclose.
Chad Hales, MD, PhD, FAAN The institution of Dr. Hales has received research support from BrightFocus foundation. The institution of Dr. Hales has received research support from NIH. The institution of Dr. Hales has received research support from State of Georgia. Dr. Hales has a non-compensated relationship as a committee member with AAN that is relevant to AAN interests or activities.
Yo-El Ju, MD The institution of Dr. Ju has received research support from National Institutes of Health.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Aaron Lord, MD Dr. Lord has nothing to disclose.
Matthias Mehling, MD The institution of Dr. Mehling has received research support from Swiss National Science Foundation. The institution of Dr. Mehling has received research support from Roche. The institution of Dr. Mehling has received research support from Merck.
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Logan D. Schneider, MD Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Elisabetta Verdun Di Cantogno, MD Dr. Verdun Di Cantogno has received personal compensation for serving as an employee of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. Dr. Verdun Di Cantogno has stock in EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.
Andrew M. Wilson, MD, MS, MBA The institution of Dr. Wilson has received research support from AHRQ-PCORI. The institution of Dr. Wilson has received research support from CDC. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Academy of Neurology.
Ella Akkerman, MD Dr. Akkerman has nothing to disclose.
Jay-Jiguang Zhu, MD, PhD, FAAN The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Kiyonobu Komai, MD Dr. Komai has nothing to disclose.
Miranda M. Lim, MD, PhD Dr. Lim has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Cognition. Dr. Lim has stock in Applied Cognition. The institution of Dr. Lim has received research support from NIH. The institution of Dr. Lim has received research support from VA. The institution of Dr. Lim has received research support from Department of Defense. The institution of Dr. Lim has received research support from National Science Foundation. Dr. Lim has received publishing royalties from a publication relating to health care.
Michael J. Howell, MD, FAAN The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care.
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Xiang Fang, MD, PhD, FAAN Dr. Fang has nothing to disclose.
Cong Zhi Zhao, MD Dr. Zhao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Efficient CME. Dr. Zhao has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva.
Shruti P. Agnihotri, MD An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Manal A. Badawi, MD Dr. Badawi has nothing to disclose.
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Katy Eichinger, PhD, PT, DPT, NCS Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care.
Klemens Ruprecht, MD Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
Cen Zhang, MD Dr. Zhang has nothing to disclose.
Jason P. Mendoza, PhD Dr. Mendoza has received personal compensation for serving as an employee of Biogen. Dr. Mendoza has stock in Biogen.
Jonathan H. Smith, MD Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Deepti Zutshi, MD, FAAN Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Shasha Wu, MD, PhD Dr. Wu has nothing to disclose.
James D. Berry, MD MPH Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Tuhin Virmani, MD, PhD, FAAN The institution of Dr. Virmani has received research support from Parkinson's Foundation.
Fawzi Babtain, MD Dr. Babtain has nothing to disclose.
Ezequiel A. Piccione, MD, FAAN Dr. Piccione has nothing to disclose.
Maysaa M. Basha, MD, FAAN Dr. Basha has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN Dr. Sankaraneni has nothing to disclose.
Volodymyr Vulkanov, MD Dr. Vulkanov has nothing to disclose.
Barry M. Czeisler, MD, MS, MHPE, FAAN Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroStat Consulting LLC. Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroStat Consulting LLC. Dr. Czeisler has stock in Brainspace. Dr. Czeisler has received publishing royalties from a publication relating to health care.
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Lei Liu, MD, PhD Dr. Liu has nothing to disclose.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Erika S. Horta, MD Dr. Horta has nothing to disclose.
Jori Fleisher, MD, MSCE, FAAN The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Meriem K. Bensalem Owen, MD Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a Principle Investigator (PI) with Xenon. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with UCB. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with NeuroPace.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Nancy Gadallah, DO Dr. Gadallah has nothing to disclose.
Chirantan Banerjee, MD, MPH Dr. Banerjee has nothing to disclose.
Mika Komori Mika Komori has received personal compensation for serving as an employee of Eli Lilly K.K..
Emmanuel H. During, MD Dr. During has nothing to disclose.
Jose L. Torres, MD Dr. Torres has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES, FAAN Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Mihael V. Varosanec, MD Dr. Varosanec has received research support from NIH.
Eugene L. Scharf, MD The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Christian Enzinger Christian Enzinger has nothing to disclose.
Michael Barbe No disclosure on file
Todd Herrington, MD Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic, Inc. Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MarvelBiome. Dr. Herrington has received personal compensation in the range of $0-$499 for serving as an Expert Witness for CRICO. The institution of Dr. Herrington has received research support from NIH/NINDS (K23NS099380).
Guenther Deuschl, MD, FAAN Dr. Deuschl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care.
William R. Meador, MD Dr. Meador has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ForensisGroup. The institution of Dr. Meador has received research support from PCORI. The institution of Dr. Meador has received research support from ROCHE/GENENTECH.
Benedetta Bodini, MD Dr. Bodini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Dr. Bodini has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Bodini has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bodini has received research support from Biogen.
Roshini Jain Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Koto Ishida, MD, FAAN Dr. Ishida has received publishing royalties from a publication relating to health care.
Peter Kosa, PhD Dr. Kosa has nothing to disclose.
Andrea Lazzarotto Dr. Lazzarotto has nothing to disclose.
Marta Simone Marta Simone, 11772 has nothing to disclose.
Giacomo Boffa Mr. Boffa has nothing to disclose.
Preethish Kumar Veeramani, MBBS, PhD, FRCP(Lon) Dr. Veeramani has nothing to disclose.
Kiran Polavarapu, MBBS Dr. Polavarapu has nothing to disclose.
Courtney E. McIlduff, MD The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Rachelle Dugue, MD, PhD Dr. Dugue has nothing to disclose.
Eslam H. Shosha, MD Dr. Shosha has nothing to disclose.
Thomas J. Shoemaker, MD Dr. Shoemaker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Shoemaker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Shoemaker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
Jennifer M. Martinez-Thompson, MD, FAAN Dr. Martinez-Thompson has nothing to disclose.
Nidhiben A. Anadani, MD Dr. Anadani has nothing to disclose.
Adrian Budhram, MD Dr. Budhram has nothing to disclose.
Ruta N. Yardi, MD Dr. Yardi has nothing to disclose.
Neda Sattarnezhad Oskouei, MD Dr. Sattarnezhad Oskouei has received research support from National Institutes of Health (NIH). Dr. Sattarnezhad Oskouei has received research support from National Institute of Allergy and Infectious Diseases (NIAID).
Brian J. Hanrahan, MD Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Julie A. Fields, PhD The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Takeshi Sakata Takeshi Sakata has received personal compensation for serving as an employee of Mitsubishi Tanabe.
Christina Lineback, MD Dr. Lineback has nothing to disclose.
Daniel Huddleston, MD The institution of Dr. Huddleston has received research support from NIH-NINDS 1K23NS105944-01A1. The institution of Dr. Huddleston has received research support from Michael J. Fox Foundation (MJFF-010556). The institution of Dr. Huddleston has received research support from Lewy Body Dementia Association Research Center of Excellence (Emory). The institution of Dr. Huddleston has received research support from American Parkinson's Disease Association.
Naoum P. Issa, MD, PhD The institution of Dr. Issa has received research support from NIH. Dr. Issa has received intellectual property interests from a discovery or technology relating to health care. Dr. Issa has received personal compensation in the range of $0-$499 for serving as a Study Section Member with NIH. Dr. Issa has a non-compensated relationship as a Scientific advisory board member with Theta Neurotech that is relevant to AAN interests or activities.
Harald Kropshofer Harald Kropshofer has nothing to disclose.
Oleg Y. Yerstein, MD Dr. Yerstein has nothing to disclose.
Timothy R. Fullam, MD, FAAN Dr. Fullam has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. Dr. Fullam has received publishing royalties from a publication relating to health care. Dr. Fullam has received personal compensation in the range of $500-$4,999 for serving as a ALS CDRMP Programmatic Panel with Department of War.
Andrea Kuehn Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Cemal Karakas, MD Dr. Karakas has nothing to disclose.
Maria G. Martucci, MD Dr. Martucci has nothing to disclose.
Anne Chiaramello, PhD Dr. Chiaramello has nothing to disclose.
Ruturaj Masvekar, PhD Dr. Masvekar has nothing to disclose.
Christian Barro, MD, PhD Dr. Barro has nothing to disclose.
Brian Stamm, MD Dr. Stamm has received personal compensation in the range of $10,000-$49,999 for serving as a Physician with Veterans Health Administration.
Swathy Chandrashekhar, MD Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Hyun-Wook Nah, MD Dr. Nah has nothing to disclose.
Negar Moheb, MD Dr. Moheb has nothing to disclose.
Francisco Ponce No disclosure on file
Hemal Patel, MD Dr. Patel has nothing to disclose.
Amelie Pelletier Ms. Pelletier has nothing to disclose.
Andrew C. Schomer, MD No disclosure on file
Alexandra Eid, MD Dr. Eid has nothing to disclose.
Ethan Murphy No disclosure on file
Elias Samaha, MD Dr. Samaha has nothing to disclose.
Seena Vengalil, MD Dr. Vengalil has nothing to disclose.
Jacob Yomtoob, MD Dr. Yomtoob has nothing to disclose.
S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GUIDEPOINT. Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Research and Therapy. The institution of Dr. Sajjadi has received research support from NIH.
Hrishikesh A. Lokhande Mr. Lokhande has nothing to disclose.
Vaibhav Goswami, MD Dr. Goswami has nothing to disclose.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Lakshmi Pillai Ms. Pillai has nothing to disclose.
William Hoffman, MD The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.
Lilly Chen Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Santiago Ortega Gutierrez, MD Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Christopher Melinosky, MD Dr. Melinosky has nothing to disclose.
Allison Jordan, DO Dr. Macke has nothing to disclose.
Sanjila Islam, MD Dr. Islam has nothing to disclose.
Fabiane Lima, MD No disclosure on file
Amna Imran, MD Dr. Imran has nothing to disclose.
Alicia Gonzalez-Martinez, MD Dr. Gonzalez-Martinez has nothing to disclose.
Joshua Luster, MD Dr. Luster has nothing to disclose.
Alexandre Mason Sharma, MD Dr. Mason Sharma has nothing to disclose.
Dan Tong Jia, MD Dr. Jia has nothing to disclose.
Justin Barber No disclosure on file
Ventaka Bendi, MBBS Dr. Bendi has nothing to disclose.
Pascal Benkert Pascal Benkert has nothing to disclose.
Ahmer Asif, MD Dr. Asif has nothing to disclose.
Charles Iaconangelo, PhD Dr. Iaconangelo has received personal compensation for serving as an employee of Open Health Group.
Vito A. Ricigliano Mr. Ricigliano has received personal compensation in the range of $500-$4,999 for serving as a Expert with M3 global research, Biogen and Atheneum Partners.
Vanessa Sui, MD Dr. Sui has nothing to disclose.
Vivek Mehta, MD Dr. Mehta has nothing to disclose.
Jonathan Phillips Jonathan Phillips has nothing to disclose.
Leah K. Forsberg, PhD Ms. Forsberg has nothing to disclose.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Nischay Mishra, PhD Dr. Mishra has nothing to disclose.
Christopher Jensen, PharmD Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Robert Croop, MD Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Sri Raghav S. Sista, MD Dr. Sista has nothing to disclose.
Yueqing Zhang Ms. Zhang has nothing to disclose.
Jennifer L. Durphy, MD Dr. Durphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda.
Sisira Yadala, MD, FAAN Dr. Yadala has nothing to disclose.
Parichita Choudhury, MD The institution of Dr. Choudhury has received research support from Lewy Body Dementia Association. The institution of Dr. Choudhury has received research support from Arizona Alzheimer's Consortium.
Martine Uittenbogaard, PhD No disclosure on file
Ryan Halter No disclosure on file
Stephen Apple Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Samantha Hentosh Miss Hentosh has nothing to disclose.
Sarah Verga Miss Verga has nothing to disclose.
Sean Levy No disclosure on file
Seyedamirhosein Motamedi, PhD Mr. Motamedi has nothing to disclose.
Pamela O'Dea, MD Dr. O'Dea has nothing to disclose.
Siddharth Bhattacharjee, MBBS Dr. Bhattacharjee has nothing to disclose.
Sumayyah Abumurad, MBBS Dr. Abumurad has nothing to disclose.
Charlotte Wahle Charlotte Wahle has nothing to disclose.
Anthony J. Griswold, PhD Dr. Griswold has received research support from National Institutes of Health.
Farid Rajabli, PhD Farid Rajabli has nothing to disclose.
Jennifer S. McLeland Ms. McLeland has nothing to disclose.
Aliyah J. Glover Miss Glover has nothing to disclose.
Juliane Chainakul, APRN-CNS Juliane Chainakul has nothing to disclose.
Sanjeev Roy Sanjeev Roy has received personal compensation for serving as an employee of Merck KgGA.
Shahar Shelly, MD Dr. Shelly has or had stock in Remepy.
Steffen Paschen The institution of Steffen Paschen has received research support from Deutsche Forschungsgemeinschaft. The institution of Steffen Paschen has received research support from Parkinsonfonds. The institution of Steffen Paschen has received research support from UCB .
Luis G. Manrique, MD Dr. Manrique has nothing to disclose.
Ramiro G. Castro Apolo, MD Dr. Castro Apolo has nothing to disclose.
Ashley Nelson, DO Dr. Nelson has nothing to disclose.
Alejandro Salah, MD, PhD, MBA, MHA Dr. Salah has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma.
Hilda V. Gutierrez, MD Ms. Gutierrez has nothing to disclose.
Maria Shoaib, MD Dr. Shoaib has nothing to disclose.
Nora Montealegre, MD Dr. Montealegre has nothing to disclose.
Ramsha A. Bhutta, MD Dr. Bhutta has nothing to disclose.
Marina Buciuc, MD Dr. Buciuc has nothing to disclose.
Lindsey Gurin, MD Dr. Gurin has received personal compensation in the range of $0-$499 for serving as a physician reviewer with Healthcare Quality Strategies, Inc. Dr. Gurin has received personal compensation in the range of $500-$4,999 for serving as a consultant with Human Services Research Institute.
Janette Contreras-De Lama Janette Contreras-De Lama has received personal compensation for serving as an employee of AbbVie. Janette Contreras-De Lama has stock in AbbVie.
Brett Dabruzzo, PharmD Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Caroline Olvera, MD Dr. Olvera has nothing to disclose.
Eileen Harrigan, MD Dr. Harrigan has nothing to disclose.
Maryam J. Syed, MBBS Dr. Syed has nothing to disclose.
Veronica A. Moreno Gomez, MD Dr. Moreno Gomez has nothing to disclose.
Sean W. Scarpiello, MD Dr. Scarpiello has nothing to disclose.
Keyvan Heshmati, MD Dr. Heshmati has nothing to disclose.
Carolina Gil Tommee, MD Dr. Gil Tommee has nothing to disclose.
Jonas Kruse Mr. Kruse has nothing to disclose.
Frederike Cosima Oertel, MD The institution of Dr. Oertel has received research support from AAN. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS.
Melissa Hagan Melissa Hagan has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc..
Richard Bertz Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Ashlyn G. Johnson The institution of Ms. Johnson has received research support from BrightFocus Foundation.
Ying Liu Ying Liu has nothing to disclose.
Carla Kim Carla Kim has nothing to disclose.
Jeffrey Zhang The institution of Jeffrey Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BioVie.
Malgorzata Ciepielewska Malgorzata Ciepielewska has received personal compensation for serving as an employee of Mitsubishi Tanable Pharma America, Inc..
Andrew J. Dutka, MD, FAAN Dr. Dutka has nothing to disclose.
Damon Salzman, MD Dr. Salzman has nothing to disclose.
Melvin W. Kong, MD Dr. Kong has nothing to disclose.
Brian Ghafari-Naraghi, RN, BSN Mr. Ghafari-Naraghi has nothing to disclose.
Areej Bushnag, MD No disclosure on file
Migvis Monduy, MD Dr. Monduy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Linda A. Piccinini, PhD An immediate family member of Dr. Piccinini has received personal compensation for serving as an employee of Biogen. Dr. Piccinini has received stock or an ownership interest from Biogen.
Colleen M. Connolly, MD Dr. Connolly has nothing to disclose.
Young-Min Kim, MD Dr. Kim has nothing to disclose.
Sunitha L. Nune, MD Dr. Nune has nothing to disclose.
Sara A. Klein, MD Dr. Klein has nothing to disclose.
Cory P. Hackmyer, DO Dr. Hackmyer has nothing to disclose.
Kaitlin Seibert, MD Dr. Seibert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Seibert has received research support from Retirement Research Foundation. The institution of Dr. Seibert has received research support from Center for Healthcare Delivery Science and Innovation. Dr. Seibert has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Eli Lilly. Dr. Seibert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with NeurologyLive.
Claudia Vallin, DO Dr. Vallin has nothing to disclose.
Abhilasha P. Boruah Ms. Boruah has nothing to disclose.
Taryn Liu, MD Dr. Liu has nothing to disclose.
Dan Chapman, DO Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Chapman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Chapman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Chapman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics.
Cole P. Denkensohn, MD Dr. Denkensohn has nothing to disclose.
Matthew Leoni, MD, MBA Dr. Leoni has received personal compensation for serving as an employee of Cerevel Therapeutics.
Jeffrey Karduck, MD Dr. Karduck has nothing to disclose.
Cassie L. Nankee, MD Dr. Nankee has nothing to disclose.
Mengxuan Tang Ms. Tang has nothing to disclose.
Sydney M. Spagna, MD Dr. Spagna has nothing to disclose.
Charles J. Kidd, MD Dr. Kidd has nothing to disclose.
Hamidreza Abbasi, MD Dr. Abbasi has nothing to disclose.
Melody Merati, DO Dr. Merati has nothing to disclose.
Montserrat Montesinos, MD Dr. Montesinos has nothing to disclose.
Manizhe Eslami-Amirabadi, MD Dr. Eslami-Amirabadi has nothing to disclose.
Behnam Sabayan, MD, PhD, MSc, FAHA The institution of Dr. Sabayan has received research support from NIH. The institution of Dr. Sabayan has received research support from Lilly .
Jenifer Moceri, DO Dr. Moceri has nothing to disclose.
Juan J. Mendez Gallardo, MD Dr. Mendez Gallardo has nothing to disclose.
Brady T. Mannett, DO Dr. Mannett has nothing to disclose.
Rupin Singh, MD Dr. Singh has nothing to disclose.
Nora Ko, MD Dr. Ko has nothing to disclose.
Alessia Manni Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi genzime. Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Alessia Manni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Cleo Zarina A. Reyes, MD Dr. Reyes has nothing to disclose.
Kyle Tse, MD Dr. Tse has nothing to disclose.
Oleksandra Los, MD Dr. Los has nothing to disclose.
Saniya Pervin, MD Dr. Pervin has nothing to disclose.
Jorge L. Rodriguez Lee, MD Dr. Rodriguez Lee has nothing to disclose.
Irene C. Yator, MD Ms. Yator has nothing to disclose.
Mellad Khoshnood, MD Dr. Khoshnood has nothing to disclose.
Amy Espinal, MD Dr. Espinal has nothing to disclose.
Praveen Ramani, MBBS Dr. Ramani has nothing to disclose.
Schweta P. Rane, MBBS Dr. Rane has nothing to disclose.
Nidhi Kikkeri, MD Dr. Kikkeri has nothing to disclose.
Saba Jafarpour, MD Dr. Jafarpour has nothing to disclose.
James W. Wiggins, MD, PhD Dr. Wiggins has nothing to disclose.
Adam Kroopnick, MD Dr. Kroopnick has nothing to disclose.
Wonhee Lee, MD Dr. Lee has nothing to disclose.
Reem Waziry, PhD, MBBCh, MPH Dr. Waziry has nothing to disclose.
Jeff W. Jin Mr. Jin has nothing to disclose.
Anu Paul, PhD Anu Paul has nothing to disclose.
Harshadayani Jagadish Kumar, MBBS Dr. Jagadish Kumar has nothing to disclose.
Saraswati Nashi, MD Dr. Nashi has nothing to disclose.
Pietro Iaffaldano Pietro Iaffaldano has nothing to disclose.
Tommaso Guerra Tommaso Guerra has nothing to disclose.
Allyson Heng, MD Dr. Heng has nothing to disclose.
Mainak Bardhan, MD Dr. Bardhan has nothing to disclose.
Rachel Gurrell, PhD Dr. Gurrell has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Gurrell has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Gurrell has stock in Pfizer Ltd.
Lilly Frohlich, MPH Ms. Frohlich has received personal compensation for serving as an employee of Cerevel Therapeutics.
Jennie Burns, MD Dr. Burns has nothing to disclose.
Ting-Yi Lin, MD Dr. Lin has nothing to disclose.
Rudmila Rashid, MD Miss Rashid has nothing to disclose.
Daniel Selness Mr. Selness has received personal compensation for serving as an employee of Mitsubishi Tanabe.
Leigham Breckenridge Mr. Breckenridge has nothing to disclose.
Stephen Kaplita No disclosure on file
Rajinder Bhardwaj The institution of Rajinder Bhardwaj has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biohaven .
Natallia Kharytaniuk, MBBS Dr. Kharytaniuk has received research support from NIHR UCLH BRC Deafness and Hearing Problems Theme .
Ann Dandurand No disclosure on file
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Wayne Macfadden, MD, PT Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma.
Edward Kim, MD Dr. Kim has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Kim has stock in Biohaven Pharmaceuticals.
Douglas S. Fuller Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
Kranthi K. Mandava Mr. Mandava has nothing to disclose.
Andrea O. Busicescu Ms. Busicescu has nothing to disclose.
Soleil Samaan No disclosure on file
Meenakshi Bhattacharjee No disclosure on file
Margaret Kelly Specht Mrs. Kelly Specht has nothing to disclose.
Emily Liu Ms. Liu has nothing to disclose.
Jingxiao Zhang Dr. Zhang has nothing to disclose.
Allaire Doussan No disclosure on file
Gopikrishnan Unnikrishnan Gopikrishnan Unnikrishnan has nothing to disclose.
Ashley Barasa, MD Miss Barasa has nothing to disclose.
Ryan Ward Mr. Ward has nothing to disclose.
Isabelle Havis Ms. Havis has nothing to disclose.
Moises-Zacariah Garcia Mr. Garcia has nothing to disclose.
Arthur Andrada, Jr. Mr. Andrada has nothing to disclose.
Henry Skrehot Mr. Skrehot has nothing to disclose.
Alexandra Vallera Miss Vallera has nothing to disclose.
Nikhil B. Bhana Mr. Bhana has nothing to disclose.
Carolina Parra Cantu, MD Dr. Cantu has nothing to disclose.
Mali C. Coray Ms. Coray has received research support from Swiss National Science Foundation (SNSF).
Polina Da Silva, Other Mrs. Da Silva has nothing to disclose.
Susana Soto Ms. Soto has nothing to disclose.
Connor Eggleston Mr. Eggleston has nothing to disclose.
Joanne Stevens, BA Ms. Stevens has stock in Jazz Pharmaceuticals.